WWB

Windward Bio Group AG - Common shares (WWB)

About Windward Bio Group AG - Common shares (WWB)

Its lead programs target thymic stromal lymphopoietin and interleukin-13 and are in clinical development. Windward Bio Group AG is a Swiss clinical-stage biotechnology company founded in 2024 that develops ultra-long-acting monoclonal antibodies for serious respiratory and dermatologic immunological diseases, including asthma, chronic obstructive pulmonary disease, and atopic dermatitis.

Details

Daily high
$29.95
Daily low
$23.40
Price at open
$25.51
52 Week High
$33.98
52 Week Low
$17.00
Market cap
397.8M
Dividend yield
-
Volume
108,609
Avg. volume
441,671
P/E ratio
-3.47

Windward Bio Group AG - Common shares News

Details

Daily high
$29.95
Daily low
$23.40
Price at open
$25.51
52 Week High
$33.98
52 Week Low
$17.00
Market cap
397.8M
Dividend yield
-
Volume
108,609
Avg. volume
441,671
P/E ratio
-3.47